255 related articles for article (PubMed ID: 23620106)
1. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis.
Hirota K; Hashimoto M; Ito Y; Matsuura M; Ito H; Tanaka M; Watanabe H; Kondoh G; Tanaka A; Yasuda K; Kopf M; Potocnik AJ; Stockinger B; Sakaguchi N; Sakaguchi S
Immunity; 2018 Jun; 48(6):1220-1232.e5. PubMed ID: 29802020
[TBL] [Abstract][Full Text] [Related]
3. Role of Th17 and IL-17 Cytokines on Inflammatory and Auto-immune Diseases.
Akhter S; Tasnim FM; Islam MN; Rauf A; Mitra S; Emran TB; Alhumaydhi FA; Khalil AA; Aljohani ASM; Al Abdulmonem W; Thiruvengadam M
Curr Pharm Des; 2023; 29(26):2078-2090. PubMed ID: 37670700
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.
Kim EY; Moudgil KD
Cytokine; 2017 Oct; 98():87-96. PubMed ID: 28438552
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets.
Furst DE; Emery P
Rheumatology (Oxford); 2014 Sep; 53(9):1560-9. PubMed ID: 24402580
[TBL] [Abstract][Full Text] [Related]
6. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.
Astry B; Harberts E; Moudgil KD
J Interferon Cytokine Res; 2011 Dec; 31(12):927-40. PubMed ID: 22149412
[TBL] [Abstract][Full Text] [Related]
7. The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases.
Tabarkiewicz J; Pogoda K; Karczmarczyk A; Pozarowski P; Giannopoulos K
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):435-49. PubMed ID: 26062902
[TBL] [Abstract][Full Text] [Related]
8. Targeting DCs for Tolerance Induction: Don't Lose Sight of the Neutrophils.
Hafkamp FMJ; Groot Kormelink T; de Jong EC
Front Immunol; 2021; 12():732992. PubMed ID: 34675923
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies.
Bianchi E; Vecellio M; Rogge L
Front Immunol; 2021; 12():770275. PubMed ID: 34630440
[No Abstract] [Full Text] [Related]
10. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.
Lai Y; Dong C
Int Immunol; 2016 Apr; 28(4):181-8. PubMed ID: 26545932
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17-A multifaceted cytokine in viral infections.
Sahu U; Biswas D; Prajapati VK; Singh AK; Samant M; Khare P
J Cell Physiol; 2021 Dec; 236(12):8000-8019. PubMed ID: 34133758
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on the role of IL-17 in autoimmune disease.
Yamada H
J Inflamm Res; 2010; 3():33-44. PubMed ID: 22096355
[TBL] [Abstract][Full Text] [Related]
13. Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.
Hofer MJ; Campbell IL
Br J Pharmacol; 2016 Feb; 173(4):716-28. PubMed ID: 25917268
[TBL] [Abstract][Full Text] [Related]
14. IL-22, a vital cytokine in autoimmune diseases.
Li J; Wu Z; Wu Y; Hu XY; Yang J; Zhu D; Wu M; Li X; Bentum-Ennin L; Hu W
Clin Exp Immunol; 2024 Apr; ():. PubMed ID: 38651179
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications.
Jiang K; Xu Y; Wang Y; Yin N; Huang F; Chen M
Cytokine Growth Factor Rev; 2024 Jun; 77():91-103. PubMed ID: 38735805
[TBL] [Abstract][Full Text] [Related]
16. Obesity alters immunopathology in cancers and inflammatory diseases.
Zhang X; Gao L; Meng H; Zhang A; Liang Y; Lu J
Obes Rev; 2023 Dec; 24(12):e13638. PubMed ID: 37724622
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation.
Gál P; Brábek J; Holub M; Jakubek M; Šedo A; Lacina L; Strnadová K; Dubový P; Hornychová H; Ryška A; Smetana K
Histochem Cell Biol; 2022 Nov; 158(5):415-434. PubMed ID: 35867145
[TBL] [Abstract][Full Text] [Related]
18. Editorial: GPCR in Inflammatory and Cancer Diseases.
Couvineau A; Gomariz RP; Tan YV
Front Endocrinol (Lausanne); 2020; 11():588157. PubMed ID: 33101216
[No Abstract] [Full Text] [Related]
19. Inflammatory and Noninflammatory Disease Activity in Rheumatoid Arthritis: The Effect of Pain on Personalized Medicine.
McWilliams DF; Walsh DA
J Rheumatol; 2023 Jun; 50(6):721-723. PubMed ID: 37003607
[No Abstract] [Full Text] [Related]
20. Precision medicine in rheumatoid arthritis: unravelling sex-driven differences in response to treatment.
Sepriano A; Nikiphorou E
Lancet Rheumatol; 2022 Oct; 4(10):e650-e651. PubMed ID: 38265956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
